SLGL: Sol-Gel Technologies Ltd. Ordinary Shares Company Profile & Statistics

Sol-Gel Technologies Ltd. Ordinary Shares Profile

About

Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.

Info & Links

CEO

Moshe Arkin

Headquarters

7 GOLDA MEIR ST, WEIZMANN SCIENCE PARK
NESS ZIONA, L3 7403650, ISRAEL

Auditor

PricewaterhouseCoopers International Limited

Share holders

Employees

Sol-Gel Technologies Ltd. Ordinary Shares Statistics

Valuation Measures

Market Capitalization²

109.82M

Enterprise Value

99.59M

Enterprise Value/EBITDA(ttm)

-20.90

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

4.05

Price to Book(mrq)

3.04

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-14.25%

Profit Margin(ttm)

-724.19%

Return on Equity(ttm)

-11.80%

Return on Invested Capital(ttm)

-28.57%

Return on Assets(ttm)

-9.39%

Income Statement

Revenue(ttm)

23.93M

Revenue Per Share(ttm)

Gross Profit(ttm)

23.93M

EBITDA(ttm)³

-4.77M

Net Income Available to Common(ttm)

-3.41M

Diluted EPS(ttm)

-1.23

Share Statistics

Beta (5Y Monthly)

1.29

52-Week Change

525.20%

S&P 500 52-Week Change

18.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

933.00K

% Held by Insiders

66.51%

% Held by Institutions

26.18%

Balance Sheet

Total Cash(mrq)

24.27M

Total Cash Per Share(mrq)

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

7.32%

Quick Ratio(mrq)

7.32%

Book Value Per Share(mrq)

11.44

Cash Flow

Operating Cash Flow Per Share(ytd)

0.21

Free Cash Flow(ytd)

573.00K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

SLGL

Sol-Gel Technologies Ltd. Ordinary Shares